“No one should die of malignant melanoma” - A. Bernard Ackerman, 1985

Skin Cancer
Institute Blog

[7 min watch] Immunotherapy for squamous cell carcinoma

By Skin Cancer Institute |December 15, 2021

In this skin cancer update video, Professor Giuseppe Argenziano and Dr Elvira Moscarella speak about the latest in squamous cell carcinoma (SCC) treatment including surgery, radiation therapy, and immunotherapy.

In the short video, Prof Argenziano and Dr Moscarella look at the emerging benefits of immunotherapy for SCC treatment, including improvements in quality of life for patients with the disease.

They further talk about which patients are candidates for immunotherapy to treat SCC, as well as the side effects and efficacy of the treatment.

See all this and much more in the full video below!


Watch the full video now:



Prof Giuseppe Argenziano is Professor of Dermatology at the Department of Dermatology, Second University of Naples; Coordinator of the Skin Cancer Unit Research Hospital Santa Maria Nuova, Reggio Emilia, Italy; President of the International Dermoscopy Society; and member of the Editorial Board of the Journal of the American Academy of Dermatology.

Giuseppe has developed early diagnosis techniques for melanoma, authored over 300 scientific works and has been invited as speaker and/or chairman in more than 400 national and international conferences in the field of dermatology. He has authored more than 450 scientific articles and more than 30 books, and his publications have received a total of 6,200 citations with an h-index value of 40 (Scopus 02/2015). He is a key presenter of the HealthCert Professional Diploma of Dermoscopy program.

Topics: skin cancer treatment, immunotherapy

Recent Posts